Subscribe


PD breaking news – EBOS reports NZ$53.9m profit

Strong first half for EBOS with Australian business up 10%. 

EBOS has just released its results for the six months to 31 December, with the local operations reporting a 10.1% increase in EBITDA. There were strong contributions across the board, with “sound growth” in Institutional Healthcare, Consumer Products and the Pharmacy businesses.The net profit after tax was NZ$53.9 million for the group.

CEO Patrick Davies said total group revenues were up 4% to NZ$3.1 billion, while the Australian healthcare business grew 6.5% to NZ$2.285 billion. Of particular note was the 25% acquisition of Good Price Pharmacy Warehouse during the period, which had seen strong levels of wholesale conversion resulting in increased sales for the Symbion wholesale business.

During the half EBOS also opened its new pharmacy distribution facility in Keysborough, Melbourne, representing a capital investment of $31 million, which Davies said reflected the company’s long term commitment to the industry.

“Our business model continues to drive the profitable development of the group and is allowing us to continue to pursue opportunities for the benefit of our customers and shareholders,” Davies said.

More information in today’s issue of Pharmacy Daily.

 


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 25 Feb 15

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

20 Feb

Guild Update 20 Feb 18 - WORKPLACE resources GUILD Members may be interested ...


20 Feb

Dispensary Corner 20 Feb 18 - SUFFERERS of conditions like irritable bowel syndrome ...


20 Feb

Meds reconciliation - HIGHER accuracy of complex medication reconciliation can ...


20 Feb

Metformin XR recall - APOTEX, in consultation with the TGA, is ...


20 Feb

Arthrem safe - FOLLOWING the NZ Medsafe "potential risk" alert ...


20 Feb

Mundipharma buys Tolmar for Eligard(R) - FOLLOWING several months of comprehensive due diligence ...


20 Feb

Precision medicine - THE future of precision medicine in Australia ...


20 Feb

Dispensing error decriminalisation - NEW legislation to protect community pharmacists in ...


20 Feb

TGA CM advertising debate - BOTH science and civil society organisations have ...


20 Feb

Pharmacy training offers - THE Pharmaceutical Society of Australia (PSA) has ...


19 Feb

Weekly Comment 19 Feb 18: Promoting your personal brand - THIS week's contributor is Heidi Dariz, General ...


19 Feb

Dispensary Corner 19 Feb 18 - PEOPLE can remain very loyal to their ...


19 Feb

Arthrem safety alert - NEW Zealand Medicines and Medical Devices Safety ...


19 Feb

Roche to buy Flatiron - ROCHE has announced it has signed a ...


19 Feb

Gannon slams vaping - AMA president Michael Gannon has highlighted the ...


19 Feb

FDA guidance x seven - THE US Food and Drug Administration (FDA) ...


19 Feb

Potent new flu vaccine - A NEW high dose influenza vaccine will ...


19 Feb

Schulze WA POTY - FORMER PDL chairman and current chairman of ...


19 Feb

WA Guild elections - NOMINATIONS are open for the election of ...


19 Feb

‘Pharmacy first’ says NHS - PARENTS of young children with minor illnesses ...



Show Pharmacy Daily items by month: